FEBS Journal

Scope & Guideline

Fostering Knowledge and Innovation in Biochemical Sciences

Introduction

Welcome to the FEBS Journal information hub, where our guidelines provide a wealth of knowledge about the journal’s focus and academic contributions. This page includes an extensive look at the aims and scope of FEBS Journal, highlighting trending and emerging areas of study. We also examine declining topics to offer insight into academic interest shifts. Our curated list of highly cited topics and recent publications is part of our effort to guide scholars, using these guidelines to stay ahead in their research endeavors.
LanguageEnglish
ISSN1742-464x
PublisherWILEY
Support Open AccessNo
CountryUnited Kingdom
TypeJournal
Convergefrom 2005 to 2024
AbbreviationFEBS J / FEBS J.
Frequency24 issues/year
Time To First Decision-
Time To Acceptance-
Acceptance Rate-
Home Page-
Address111 RIVER ST, HOBOKEN 07030-5774, NJ

Aims and Scopes

The FEBS Journal publishes high-quality research articles that span a wide range of topics in biochemistry, molecular biology, and cellular biology. The journal aims to advance our understanding of biological processes at the molecular level, with a focus on the mechanisms underlying disease and potential therapeutic interventions.
  1. Biochemical and Molecular Mechanisms:
    The journal emphasizes studies that elucidate the biochemical pathways and molecular mechanisms underpinning cellular functions and disease processes, including signaling pathways, metabolic regulation, and enzyme function.
  2. Structural Biology and Biophysics:
    Research involving the structural characterization of biological macromolecules such as proteins and nucleic acids, utilizing techniques like X-ray crystallography, NMR, and cryo-electron microscopy, is a core focus.
  3. Cellular and Developmental Biology:
    The journal covers research on cellular processes, including cell differentiation, growth, and apoptosis, as well as developmental biology, exploring how these processes are regulated at the molecular level.
  4. Cancer Biology and Therapeutics:
    A significant emphasis is placed on studies related to cancer biology, including tumor microenvironment interactions, cancer stem cells, and novel therapeutic strategies.
  5. Immunology and Microbiology:
    The journal publishes articles on immune responses, pathogen-host interactions, and the microbiome's role in health and disease, reflecting the growing interest in these areas.
  6. Neurobiology and Neurodegeneration:
    Research addressing the molecular mechanisms of neurodegenerative diseases, neuroinflammation, and neuronal signaling is prominently featured, highlighting the journal's commitment to understanding brain health.
The FEBS Journal has experienced a notable evolution in its focus areas, with several emerging themes reflecting current scientific trends and societal needs. These trends indicate a shift towards more interdisciplinary and applied research.
  1. Cancer Immunotherapy:
    Publications focusing on cancer immunotherapy have surged, highlighting the importance of understanding immune responses to tumors and the development of novel immunotherapeutic strategies.
  2. Microbiome Research:
    The role of the microbiome in health and disease is increasingly prominent, with studies examining its impact on various physiological processes and its potential as a therapeutic target.
  3. Cellular Senescence and Aging:
    Research on cellular senescence, its role in aging, and its implications for age-related diseases is gaining traction, reflecting a growing interest in understanding the biological mechanisms of aging.
  4. Gene Editing Technologies:
    The application of CRISPR and other gene editing technologies is increasingly featured, focusing on their potential for therapeutic interventions and understanding genetic diseases.
  5. Metabolism and Disease:
    Emerging studies on the links between metabolism, metabolic disorders, and diseases such as cancer and neurodegeneration are becoming more common, emphasizing the importance of metabolic pathways in health.
  6. Extracellular Vesicles:
    Research on extracellular vesicles and their roles in cell communication, disease progression, and potential therapeutic applications is gaining popularity, reflecting their significance in various biological processes.

Declining or Waning

While the FEBS Journal has maintained a broad focus on various aspects of biochemistry and molecular biology, certain themes appear to be declining in prominence over recent years. This may reflect shifts in research priorities or emerging fields of interest.
  1. Basic Enzyme Kinetics:
    Research focusing solely on basic enzyme kinetics has seen a decline, as the field increasingly emphasizes the integration of kinetic studies with structural biology and functional assays.
  2. Traditional Pharmacology:
    There is a noticeable reduction in studies centered on traditional pharmacological approaches, as the focus shifts towards molecular and genetic therapies, particularly in the context of cancer and chronic diseases.
  3. Plant Biochemistry:
    While still relevant, the volume of research specifically addressing plant biochemistry and physiology appears to be waning, potentially due to a shift towards more applied or translational research in agricultural biotechnology.
  4. Studies on Model Organisms:
    Research utilizing model organisms like yeast or Drosophila for basic biological questions is less frequent, with a trend towards more complex systems that reflect human biology more closely.
  5. In Vitro Assays:
    There seems to be a decline in the publication of studies relying solely on in vitro assays without further validation in vivo, as the scientific community increasingly values comprehensive approaches that include physiological relevance.

Similar Journals

CELL BIOLOGY INTERNATIONAL

Pioneering Research in the Heart of Cell Biology
Publisher: WILEYISSN: 1065-6995Frequency: 12 issues/year

CELL BIOLOGY INTERNATIONAL is a prestigious academic journal dedicated to the rapidly evolving field of cell biology, publishing high-quality research aimed at understanding cellular processes and their implications in various biological contexts. Published by Wiley, this journal has established its relevance with an H-Index that reflects its robust citation impact and a commendable Scopus Rank of #111 out of 285 in the field of Biochemistry, Genetics, and Molecular Biology, positioning it in the 61st percentile. Although it operates under a traditional subscription model, its influential insights are crucial for researchers, professionals, and students alike who are seeking cutting-edge developments in cellular mechanisms and their applications in medicine. The journal spans contributions dating back to 1993, providing a rich archive of knowledge that continues to shape the discourse within the scientific community. With a strong category ranking of Q3 in Cell Biology and Q2 in Medicine (miscellaneous) as of 2023, CELL BIOLOGY INTERNATIONAL stands as a reliable platform for disseminating transformative science in the cellular domain.

FASEB BioAdvances

Unlocking the Secrets of Life Sciences
Publisher: WILEYISSN: Frequency: 12 issues/year

FASEB BioAdvances, published by WILEY, is an esteemed open-access journal dedicated to advancing the fields of biochemistry, molecular biology, and physiology. Since its inception in 2019, the journal has rapidly established a significant presence within the academic community, boasting an impressive impact factor reflective of its Q2 and Q3 standings across various categories, including Biochemistry, Genetics and Molecular Biology, Cancer Research, Molecular Medicine, and Physiology. The journal aims to disseminate high-quality research and innovative findings to enhance the understanding of biological processes, making it a vital resource for researchers, professionals, and students alike. With its commitment to open access, FASEB BioAdvances ensures that groundbreaking research is available to a global audience, facilitating collaboration and exploration in these rapidly evolving scientific domains.

NEUROCHEMISTRY INTERNATIONAL

Unveiling Insights in Cellular and Molecular Neuroscience
Publisher: PERGAMON-ELSEVIER SCIENCE LTDISSN: 0197-0186Frequency: 10 issues/year

NEUROCHEMISTRY INTERNATIONAL, published by Pergamon-Elsevier Science Ltd, offers a premier platform for researchers and professionals in the realms of cell biology and cellular and molecular neuroscience. Established in 1980 and continuing its passion for advancing the field, this esteemed journal enhances scientific collaboration with a notable 2023 Q2 ranking in both relevant categories, placing it among the top-tier publications in its discipline with a Scopus rank of 23/97 for Cellular and Molecular Neuroscience. With its focus on groundbreaking research, the journal provides a wealth of vital data and insights that drive forward our understanding of neurochemistry and its implications in health and disease. While not an Open Access journal, NEUROCHEMISTRY INTERNATIONAL is integral for professionals, academics, and students aiming to stay at the forefront of neurobiological research innovations, making significant contributions to both academia and clinical applications.

Frontiers in Bioscience-Landmark

Uncovering Landmark Research in Life Sciences
Publisher: IMR PRESSISSN: 2768-6701Frequency: 12 issues/year

Frontiers in Bioscience-Landmark is a prestigious journal published by IMR PRESS that focuses on a diverse array of topics within the fields of biochemistry, genetics, molecular biology, immunology, and microbiology. With the ISSN 2768-6701 and E-ISSN 2768-6698, this journal has carved a significant niche since its inception in 1996, making its mark in contributions to the scientific community all the way through to 2024. Having achieved a respectable Q2 cohort rank in multiple categories, including biochemistry and immunology, it stands out for its impactful research, evidenced by its current Scopus rankings which highlight it as a vital resource for ongoing studies and advancements in the biosciences. Despite not being open access, the journal ensures that readers have access to high-quality research articles that are peer-reviewed and designed to foster academic discourse. The importance of Frontiers in Bioscience-Landmark lies in its commitment to disseminating innovative findings that can significantly enhance our understanding of biological sciences, making it an essential read for researchers, professionals, and students alike.

BIOSCIENCE REPORTS

Connecting Researchers with Groundbreaking Findings
Publisher: PORTLAND PRESS LTDISSN: 0144-8463Frequency: 6 issues/year

BIOSCIENCE REPORTS, published by Portland Press Ltd, is a prestigious journal dedicated to advancing the fields of biochemistry, biophysics, cell biology, and molecular biology. Founded in 1981, the journal has established itself as a vital resource for researchers and professionals, boasting a significant impact factor and high rankings within its categories, including Q2 in Biochemistry and Q1 in Biophysics as of 2023. The journal’s commitment to high-quality, peer-reviewed research ensures that it remains an influential platform for the dissemination of cutting-edge scientific findings. While it operates under a traditional subscription model, it offers various access options to accommodate the needs of the scientific community. With ongoing publication through 2024, BIOSCIENCE REPORTS continues to play a crucial role in shaping discussions in the life sciences and fostering innovative research in biology.

FEBS LETTERS

Connecting Researchers Through Groundbreaking Insights
Publisher: WILEYISSN: 0014-5793Frequency: 24 issues/year

FEBS LETTERS, published by Wiley, is a prestigious journal that has firmly established its place in the fields of biochemistry, biophysics, genetics, molecular biology, cell biology, and structural biology. With an esteemed history dating back to 1968, this journal continues to be a vital resource for researchers and professionals involved in the biological sciences. It boasts impressive quartile rankings, including Q1 statuses in several categories such as Biochemistry and Genetics, reflecting its high impact factor and significant contribution to scientific discourse. FEBS LETTERS provides a platform for innovative findings and critical reviews, fostering the exchange of knowledge and ideas within the scientific community. Although it operates under a subscription model, the journal ensures broad dissemination of groundbreaking research through its rigorous peer-review process. The vibrant discussions encouraged by articles published in FEBS LETTERS aim to inspire current and future generations of scientists to push the boundaries of biological understanding, making it an indispensable resource for anyone dedicated to advancing their knowledge in these dynamic fields.

CELL DEATH AND DIFFERENTIATION

Pioneering Research in the Biology of Life and Death
Publisher: SPRINGERNATUREISSN: 1350-9047Frequency: 12 issues/year

CELL DEATH AND DIFFERENTIATION, published by SpringerNature, is a leading peer-reviewed journal that has been at the forefront of advancing knowledge in the fields of cell biology and molecular biology since its inception in 1994. With an impressive impact factor and ranking in the Q1 quartile for both categories as of 2023, it is recognized as an essential resource for researchers and professionals dedicated to understanding the intricate processes of cellular death and differentiation. The journal publishes high-quality original research articles, reviews, and commentaries, fostering an interdisciplinary dialogue among scientists exploring the molecular mechanisms that underpin these fundamental biological processes. With its commitment to excellence, CEL DEATH AND DIFFERENTIATION bridges gaps in knowledge and stimulates innovation within the scientific community. To access cutting-edge research from this prestigious journal, you may visit their website for subscription options and explore a wealth of knowledge that is crucial for advancing the frontiers of biological research.

Cell Discovery

Advancing the Frontiers of Cellular Science
Publisher: SPRINGERNATUREISSN: Frequency: 1 issue/year

Cell Discovery, published by SPRINGERNATURE, is a premier open access journal in the dynamic fields of Biochemistry, Cell Biology, Genetics, and Molecular Biology. Since its inception in 2015, this journal has established itself as a key platform for disseminating high-impact research and is recognized with a Q1 ranking across all its core categories for the year 2023. With its remarkable Scopus rankings—7th in Genetics, 9th in Biochemistry, 13th in Molecular Biology, and 15th in Cell Biology—Cell Discovery positions itself among the elite journals in life sciences, showcasing the most innovative breakthroughs and comprehensive reviews. Based in the United Kingdom, this journal operates under an open access model, ensuring that groundbreaking discoveries are readily available to researchers, professionals, and students around the globe. With a commitment to advancing scientific knowledge, Cell Discovery welcomes contributions that push the frontiers of our understanding in cellular and genetic sciences.

MOLECULAR AND CELLULAR BIOCHEMISTRY

Elevating Knowledge in Biochemistry Since 1973
Publisher: SPRINGERISSN: 0300-8177Frequency: 12 issues/year

MOLECULAR AND CELLULAR BIOCHEMISTRY, an esteemed journal published by SPRINGER, serves as a prominent platform in the fields of biochemistry and molecular biology. With a history of dissemination since 1973, this journal has made significant contributions to the understanding of biochemical processes at the molecular level. The MOLECULAR AND CELLULAR BIOCHEMISTRY journal focuses on a myriad of topics including but not limited to cellular biochemistry, clinical biochemistry, and interdisciplinary approaches in medicine, boasting a commendable categorization in the 2023 Scopus ranks where it falls under Q3 in Cell Biology, Q2 in Clinical Biochemistry, Q1 in Medicine (miscellaneous), and Q2 in Molecular Biology. Although the journal is not open access, it provides access options through institutional subscriptions, making valuable research accessible to a wider audience. With its rigorous peer-review process and high impact within the scientific community, this journal aims to advance knowledge and stimulate exploration in biochemical research, making it essential reading for researchers, professionals, and students alike.

Cell and Bioscience

Empowering Knowledge Sharing in Molecular Biology
Publisher: BMCISSN: Frequency: 1 issue/year

Cell and Bioscience is a prestigious open-access journal published by BMC that has been at the forefront of biochemistry, genetics, and molecular biology since its inception in 2011. With an impressive impact factor, this journal has established itself as a vital resource for researchers and professionals in these rapidly advancing fields, reflecting its high ranking of #29 out of 221 in the Scopus classification and placing it in the 87th percentile. Based in the United Kingdom, Cell and Bioscience aims to foster innovation and dissemination of research findings addressing critical biological questions through rigorous peer-reviewed articles and inter-disciplinary approaches. The journal's open-access model ensures unrestricted access to transformative research, promoting collaboration and knowledge sharing among academics, students, and practitioners worldwide. With a commitment to maintaining excellence in the field, Cell and Bioscience provides an essential platform for those looking to contribute to the evolving landscape of biosciences.